Crescent Capital BDC (FCRX) EBITDA (2021 - 2026)

Crescent Capital BDC (FCRX) has 6 years of EBITDA data on file, last reported at -$21.9 million in Q1 2026.

• For the quarter ending Q1 2026, EBITDA rose 12.55% year-over-year to -$21.9 million; the trailing twelve-month figure through Mar 2026 stood at $111.1 million (up 305.31% YoY), and the FY2025 full-year result was $66.9 million, up 162.67% from the prior year.
• EBITDA for Q1 2026 stood at -$21.9 million, down from $141.8 million in the prior quarter.
• Across five years, EBITDA topped out at $141.8 million in Q4 2025 and bottomed at -$160.1 million in Q4 2023.
• The 5-year median for EBITDA is -$14.1 million (2022), against an average of -$1.6 million.
• The widest annual swing landed in 2022, when EBITDA jumped 1008.51%; it then tumbled 266.28% in 2023.
• A 5-year view of EBITDA shows it stood at $98.2 million in 2022, then slumped by 263.04% to -$160.1 million in 2023, then soared by 83.85% to -$25.8 million in 2024, then jumped by 648.54% to $141.8 million in 2025, then tumbled by 115.42% to -$21.9 million in 2026.
• The last three EBITDA figures came in at -$21.9 million (Q1 2026), $141.8 million (Q4 2025), and $16.9 million (Q3 2025), per Business Quant data.

Peer Comparison